Search Results - "Diabetes technology & therapeutics"

Refine Results
  1. 1

    State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018 by Foster, Nicole C, Beck, Roy W, Miller, Kellee M, Clements, Mark A, Rickels, Michael R, DiMeglio, Linda A, Maahs, David M, Tamborlane, William V, Bergenstal, Richard, Smith, Elizabeth, Olson, Beth A, Garg, Satish K

    Published in Diabetes technology & therapeutics (01-02-2019)
    “…To provide a snapshot of the profile of adults and youth with type 1 diabetes (T1D) in the United States and assessment of longitudinal changes in T1D…”
    Get more information
    Journal Article
  2. 2

    The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes by Vigersky, Robert A, McMahon, Chantal

    Published in Diabetes technology & therapeutics (01-02-2019)
    “…There has been recent recognition of the limitations of hemoglobin A1C (HbA1C) in describing both short- and long-term glycemic control. Continuous glucose…”
    Get more information
    Journal Article
  3. 3

    One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology by Breton, Marc D, Kovatchev, Boris P

    Published in Diabetes technology & therapeutics (01-09-2021)
    “…The t:slim X2™ insulin pump with Control-IQ technology from Tandem Diabetes Care is an advanced hybrid closed-loop system that was first commercialized in the…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6

    Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes by Lu, Jingyi, Ma, Xiaojing, Shen, Yun, Wu, Qiang, Wang, Ren, Zhang, Lei, Mo, Yifei, Lu, Wei, Zhu, Wei, Bao, Yuqian, Vigersky, Robert A, Jia, Weiping, Zhou, Jian

    Published in Diabetes technology & therapeutics (01-02-2020)
    “…Time in range (TIR) is an emerging metric of glycemic control and is reported to be associated with microvascular complications of diabetes. We sought to…”
    Get more information
    Journal Article
  7. 7

    Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users by Silva, Julien Da, Lepore, Giuseppe, Battelino, Tadej, Arrieta, Arcelia, Castañeda, Javier, Grossman, Benyamin, Shin, John, Cohen, Ohad

    Published in Diabetes technology & therapeutics (01-02-2022)
    “…The MiniMed™ 780G system includes an advanced hybrid closed loop (AHCL) algorithm that provides both automated basal and correction bolus insulin delivery. The…”
    Get more information
    Journal Article
  8. 8

    Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities by Rodbard, David

    Published in Diabetes technology & therapeutics (01-02-2016)
    “…Continuous glucose monitoring (CGM) provides information unattainable by intermittent capillary blood glucose, including instantaneous real-time display of…”
    Get more information
    Journal Article
  9. 9

    The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System by Bailey, Timothy, Bode, Bruce W, Christiansen, Mark P, Klaff, Leslie J, Alva, Shridhara

    Published in Diabetes technology & therapeutics (01-11-2015)
    “…The purpose of the study was to evaluate the performance and usability of the FreeStyle(®) Libre™ Flash glucose monitoring system (Abbott Diabetes Care,…”
    Get more information
    Journal Article
  10. 10

    Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes by Rodbard, David

    Published in Diabetes technology & therapeutics (01-06-2017)
    “…Continuous Glucose Monitoring (CGM) has been demonstrated to be clinically valuable, reducing risks of hypoglycemia and hyperglycemia, glycemic variability…”
    Get more information
    Journal Article
  11. 11

    Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities by Garg, Satish K, Rodbard, David, Hirsch, Irl B, Forlenza, Gregory P

    Published in Diabetes technology & therapeutics (01-06-2020)
    “…The current COVID-19 pandemic provides an incentive to expand considerably the use of telemedicine for high-risk patients with diabetes, and especially for the…”
    Get more information
    Journal Article
  12. 12

    Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity by Tornese, Gianluca, Ceconi, Viola, Monasta, Lorenzo, Carletti, Claudia, Faleschini, Elena, Barbi, Egidio

    Published in Diabetes technology & therapeutics (01-06-2020)
    “…To limit the spread of coronavirus disease 2019 (COVID-19), governments have ordered a series of restrictions that may affect glycemic control in individuals…”
    Get more information
    Journal Article
  13. 13

    Racial-Ethnic Disparities in Diabetes Technology use Among Young Adults with Type 1 Diabetes by Agarwal, Shivani, Schechter, Clyde, Gonzalez, Jeffrey, Long, Judith A

    Published in Diabetes technology & therapeutics (01-04-2021)
    “…Recent studies highlight racial-ethnic disparities in insulin pump and continuous glucose monitor (CGM) use in people with type 1 diabetes (T1D), but drivers…”
    Get more information
    Journal Article
  14. 14

    Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes by Forlenza, Gregory P, Pinhas-Hamiel, Orit, Liljenquist, David R, Shulman, Dorothy I, Bailey, Timothy S, Bode, Bruce W, Wood, Michael A, Buckingham, Bruce A, Kaiserman, Kevin B, Shin, John, Huang, Suiying, Lee, Scott W, Kaufman, Francine R

    Published in Diabetes technology & therapeutics (01-01-2019)
    “…To evaluate the safety of in-home use of the MiniMed™ 670G system with SmartGuard™ technology in children with type 1 diabetes (T1D). Participants (N = 105,…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17

    Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes by Wadwa, R Paul, Laffel, Lori M, Shah, Viral N, Garg, Satish K

    Published in Diabetes technology & therapeutics (01-06-2018)
    “…Frequent use of continuous glucose monitoring (CGM) systems is associated with improved glycemic outcomes in persons with diabetes, but the need for…”
    Get more information
    Journal Article
  18. 18

    Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator by Shah, Viral N, Laffel, Lori M, Wadwa, R Paul, Garg, Satish K

    Published in Diabetes technology & therapeutics (01-06-2018)
    “…This study assessed the accuracy of a factory-calibrated 10-day real-time continuous glucose monitoring (CGM) system (G6), which includes an automated sensor…”
    Get more information
    Journal Article
  19. 19

    Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes by Garg, Satish K, Kipnes, Mark, Castorino, Kristin, Bailey, Timothy S, Akturk, Halis Kaan, Welsh, John B, Christiansen, Mark P, Balo, Andrew K, Brown, Sue A, Reid, Jennifer L, Beck, Stayce E

    Published in Diabetes technology & therapeutics (01-06-2022)
    “…We evaluated the accuracy and safety of a seventh generation (G7) Dexcom continuous glucose monitor (CGM) during 10.5 days of use in adults with diabetes…”
    Get more information
    Journal Article
  20. 20